pharma · Schizophrenia · Alzheimer's Disease Psychosis · ACAD
Acadia Pharmaceuticals
Acadia Pharmaceuticals B.V.
Acadia Pharmaceuticals trial registry — 49 ClinicalTrials.gov studies with program phase, status, and indication context.
Indianapolis, USA HQ
17 Employees
Public company Type
ACAD · NYSE Ticker
Company details
- Status
- Public
- HQ
- Indianapolis, USA
- Employees
- 17
- Programs
- 32
- Drugs
- 15
- Patents
- 77
Acadia Pharmaceuticals clinical trials
Registry index of 49 ClinicalTrials.gov studies linked to Acadia Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Acadia Pharmaceuticals trial registry — 49 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Acadia Pharmaceuticals.
-
Placebo — Phase 3
Clinical update -
Pimavanserin — Phase 2
Clinical update -
pimavanserin tartrate — Phase 3
Clinical update -
Pimavanserin tartrate — Phase 2
Clinical update -
Pimavanserin tartrate (ACP-103) — Phase 3
Clinical update -
Pimavanserin Tartrate 34 Mg ORAL CAPSULE [NUPLAZID] — Phase 2
Clinical update -
Pimavanserin — Phase 2
Clinical update -
Pimavanserin — Approved
Clinical update
Trial registry
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗